serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.526 Hydrocarbons, Halogenated .
D02.455.526.728 Mustard Compounds .
D02.455.526.728.650 Nitrogen Mustard Compounds .
D02.455.526.728.650.275 Estramustine .
D02.455.526.728.650.730 Phosphoramide Mustards .
D02.455.526.728.650.730.243 Cyclophosphamide .
D02.705 Organophosphorus Compounds .
D02.705.672 Phosphoramides .
D02.705.672.500 Phosphoramide Mustards .
D02.705.672.500.243 Cyclophosphamide .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.129 Azoles .
D03.383.129.308 Imidazoles .
D03.383.129.308.030 Aminoimidazole Carboxamide .
D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.365 Estranes .
D04.210.500.365.415 Estrenes .
D04.210.500.365.415.248 Estradiol .
D04.210.500.365.415.248.320 Estramustine .
D05 Macromolecular Substances .
D05.750 Polymers .
D05.750.078 Biopolymers .
D05.750.078.562 Glucans .
D05.750.078.562.272 Dextrans .
D09 Carbohydrates .
D09.698 Polysaccharides .
D09.698.365 Glucans .
D09.698.365.272 Dextrans .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.276 Intercellular Signaling Peptides and Proteins .
D12.644.276.860 Nerve Growth Factors .
D12.644.276.860.381 Glial Cell Line-Derived Neurotrophic Factors .
D12.644.276.860.381.500 Glial Cell Line-Derived Neurotrophic Factor .
D12.776 Proteins .
D12.776.395 Glycoproteins .
D12.776.395.550 Membrane Glycoproteins .
D12.776.395.550.489 Histocompatibility Antigens Class I .
D12.776.395.550.489.500 HLA-B Antigens .
D12.776.395.550.489.500.510 HLA-B51 Antigen .
D12.776.467 Intercellular Signaling Peptides and Proteins .
D12.776.467.860 Nerve Growth Factors .
D12.776.467.860.381 Glial Cell Line-Derived Neurotrophic Factors .
D12.776.467.860.381.500 Glial Cell Line-Derived Neurotrophic Factor .
D12.776.543 Membrane Proteins .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.439 Histocompatibility Antigens Class I .
D12.776.543.550.439.500 HLA-B Antigens .
D12.776.543.550.439.500.510 HLA-B51 Antigen .
D12.776.631 Nerve Tissue Proteins .
D12.776.631.600 Nerve Growth Factors .
D12.776.631.600.381 Glial Cell Line-Derived Neurotrophic Factors .
D12.776.631.600.381.500 Glial Cell Line-Derived Neurotrophic Factor .
D23 Biological Factors .
D23.050 Antigens .
D23.050.301 Antigens, Surface .
D23.050.301.500 Histocompatibility Antigens .
D23.050.301.500.100 Histocompatibility Antigens Class I .
D23.050.301.500.100.500 HLA-B Antigens .
D23.050.301.500.100.500.510 HLA-B51 Antigen .
D23.050.301.500.450 HLA Antigens .
D23.050.301.500.450.380 HLA-B Antigens .
D23.050.301.500.450.380.510 HLA-B51 Antigen .
D23.050.705 Isoantigens .
D23.050.705.552 Histocompatibility Antigens .
D23.050.705.552.100 Histocompatibility Antigens Class I .
D23.050.705.552.100.500 HLA-B Antigens .
D23.050.705.552.100.500.510 HLA-B51 Antigen .
D23.050.705.552.450 HLA Antigens .
D23.050.705.552.450.380 HLA-B Antigens .
D23.050.705.552.450.380.510 HLA-B51 Antigen .
D23.529 Intercellular Signaling Peptides and Proteins .
D23.529.850 Nerve Growth Factors .
D23.529.850.381 Glial Cell Line-Derived Neurotrophic Factors .
D23.529.850.381.500 Glial Cell Line-Derived Neurotrophic Factor .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Cyclophosphamide .
B-518 .
Cyclophosphamide Anhydrous .
Cyclophosphamide Monohydrate .
Cyclophosphamide, (R)-Isomer .
Cyclophosphamide, (S)-Isomer .
Cyclophosphane .
Cytophosphan .
Cytophosphane .
Cytoxan .
Endoxan .
NSC-26271 .
Neosar .
Procytox .
Sendoxan .
Anhydrous, Cyclophosphamide .
B 518 .
B518 2751 .
Monohydrate, Cyclophosphamide .
NSC 26271 .
NSC26271 .
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. .
1.00
 
Aminoimidazole Carboxamide .
Ba 2756 .
Carboxamide, Aminoimidazole .
An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases. .
0.49
 
HLA-B51 Antigen .
HLA Class I Histocompatibility Antigen, B-51 alpha Chain .
HLA-B51 .
Antigen, HLA-B51 .
HLA B51 Antigen .
HLA Class I Histocompatibility Antigen, B 51 alpha Chain .
A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*51 allele family. .
0.46
 
Estramustine .
Emcyt .
Estracyt .
Estramustin Phosphate .
Estramustine Phosphate Sodium .
Leo-275 .
NSC-89199 .
Leo 275 .
Leo275 .
NSC 89199 .
NSC89199 .
Phosphate Sodium, Estramustine .
Phosphate, Estramustin .
Estramustinphosphate .
A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties. .
0.45
 
Dextrans .
Dextran .
Dextran 40 .
Dextran 40000 .
Dextran 70 .
Dextran 75 .
Dextran 80 .
Dextran B-1355 .
Dextran B-1355-S .
Dextran B1355 .
Dextran B512 .
Dextran Derivatives .
Dextran M 70 .
Dextran T 70 .
Dextran T-40 .
Dextran T-500 .
Hemodex .
Hyskon .
Infukoll .
Macrodex .
Polyglucin .
Promit .
Rheodextran .
Rheoisodex .
Rheomacrodex .
Rheopolyglucin .
Rondex .
Saviosol .
Dextran B 1355 .
Dextran B 1355 S .
Dextran T 40 .
Dextran T 500 .
A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. .
0.39
 
Glial Cell Line-Derived Neurotrophic Factor .
GDNF 27545 .
GDNF Growth Factor .
Glial Cell-Line Derived Neurotrophic Factor .
Glial Cell Line Derived Neurotrophic Factor .
Growth Factor, GDNF .
Glial Cell-Line Derived Neurotrophic Factor .
The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE. .
0.36